EUVIMEDEUVIMED entdecken
Open Access

Suppression of Lung Oxidative Stress, Inflammation, and Fibrosis following Nitrogen Mustard Exposure by the Selective Farnesoid X Receptor Agonist Obeticholic Acid

Jaclynn A Meshanni iD, Jordan M Lee, Kinal N Vayas, Rachel Sun, Chenghui Jiang, Grace L Guo iD, Andrew J Gow, Jeffrey D Laskin, Debra L Laskin iD

The Journal of Pharmacology and Experimental Therapeutics · 2024

DOI: 10.1124/jpet.123.001557 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2024. Verfasst von Jaclynn A Meshanni und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy (J.A.M., J.M.L., K.N.V., R.S., C.J., G.L.G., A.J.G., D.L.L.) and Departmen…. Hauptthemen laut MEDLINE: Mechlorethamine, Lung Injury. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nitrogen mustard (NM) is a cytotoxic vesicant known to cause pulmonary injury that can progress to fibrosis. NM toxicity is associated with an influx of inflammatory macrophages in the lung. Farnesoid X receptor (FXR) is a nuclear receptor involved in bile acid and lipid homeostasis that has anti-inflammatory activity. In these studies, we analyzed the effects of FXR activation on lung injury, oxidative stress, and fibrosis induced by NM. Male Wistar rats were exposed to phosphate-buffered saline (vehicle control) or NM (0.125 mg/kg) by intratracheal Penncentury-MicroSprayer aerosolization; this was followed by treatment with the FXR synthetic agonist, obeticholic acid (OCA, 15 mg/kg), or vehicle control (0.13-0.18 g peanut butter) 2 hours later and then once per day, 5 days per week thereafter for 28 days. NM caused histopathological changes in the lung, including epithelial thickening, alveolar circularization, and pulmonary edema. Picrosirius red staining and lung hydroxyproline content were increased, indicative of fibrosis; foamy lipid-laden macrophages were also identified in the lung. This was associated with aberrations in pulmonary function, including increases in resistance and hysteresis. Following NM exposure, lung expression of HO-1 and iNOS, and the ratio of nitrates/nitrites in bronchoalveolar lavage fluid (BAL), markers of oxidative stress increased, along with BAL levels of inflammatory proteins, fibrinogen, and sRAGE. Administration of OCA attenuated NM-induced histopathology, oxidative stress, inflammation, and altered lung function. These findings demonstrate that FXR plays a role in limiting NM-induced lung injury and chronic disease, suggesting that activating FXR may represent an effective approach to limiting NM-induced toxicity. SIGNIFICANCE STATEMENT: In this study, the role of farnesoid-X-receptor (FXR) in mustard vesicant-induced pulmonary toxicity was analyzed using nitrogen mustard (NM) as a model. This study's findings that administration of obeticholic acid, an FXR agonist, to rats reduces NM-induced pulmonary injury, oxidative stress, and fibrosis provide novel mechanistic insights into vesicant toxicity, which may be useful in the development of efficacious therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MechlorethamineLung InjuryRatsMaleAnimalsIrritantsRats, WistarLungFibrosisInflammationOxidative StressLipidsChenodeoxycholic Acid

Substanzen

MechlorethamineIrritantsobeticholic acidLipidsChenodeoxycholic Acid

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy (J.A.M., J.M.L., K.N.V., R.S., C.J., G.L.G., A.J.G., D.L.L.) and Department of Environmental and Occupational Health and Justice, School of Publ…

ORCID-Profile: Jaclynn A Meshanni, Grace L Guo, Debra L Laskin

Förderung

  • NIEHS NIH HHS
  • NIAMS NIH HHS

Zitieren

APA

Meshanni, J. A., Lee, J. M., Vayas, K. N., Sun, R., Jiang, C., Guo, G. L., Gow, A. J., Laskin, J. D., & Laskin, D. L. (2024). Suppression of Lung Oxidative Stress, Inflammation, and Fibrosis following Nitrogen Mustard Exposure by the Selective Farnesoid X Receptor Agonist Obeticholic Acid. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.123.001557

Vancouver

Meshanni JA, Lee JM, Vayas KN, Sun R, Jiang C, Guo GL, et al. Suppression of Lung Oxidative Stress, Inflammation, and Fibrosis following Nitrogen Mustard Exposure by the Selective Farnesoid X Receptor Agonist Obeticholic Acid. The Journal of Pharmacology and Experimental Therapeutics. 2024. doi:10.1124/jpet.123.001557

BibTeX
@article{Meshanni2024,
  author = {Meshanni, Jaclynn A and Lee, Jordan M and Vayas, Kinal N and Sun, Rachel and Jiang, Chenghui and Guo, Grace L and Gow, Andrew J and Laskin, Jeffrey D and Laskin, Debra L},
  title = {Suppression of Lung Oxidative Stress, Inflammation, and Fibrosis following Nitrogen Mustard Exposure by the Selective Farnesoid X Receptor Agonist Obeticholic Acid},
  journal = {The Journal of Pharmacology and Experimental Therapeutics},
  year = {2024},
  doi = {10.1124/jpet.123.001557}
}
Kostenlos starten →